Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed Aug 7, 2025 · 10-Q · 38 days after period end · 0000950170-25-104571
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Net Income | -$12.72M | -$8.46M | -$8.24M | -$10.47M |
| EPS Diluted | -$0.37 | -$0.25 | -$0.43 | -$1.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Jun 30, 2025 · filed Aug 7, 2025 · 38 d after period end
